Cervel Neurotech Announces Financing
Cervel Neurotech, a privately held company developing a novel, non-invasive and non-pharmacologic therapy for depression, pain and other conditions, has completed a funding round of $14.1 million. The company's existing investors, D. E. Shaw Ventures and Aberdare Ventures, participated in the equity financing.
23 April 2013•3 mins read
